Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
15 studies found for:    Pulmonary Embolism | Open Studies | NIH, U.S. Fed
Show Display Options
RSS Create an RSS feed from your search for:
Pulmonary Embolism | Open Studies | NIH, U.S. Fed
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Assessing the Prognosis of Pulmonary Embolism Using Clinical and Imaging Biomarkers (Retrospective & Prospective )
Condition: Pulmonary Embolism
Intervention:
2 Recruiting Nitric Oxide to Treat Pulmonary Embolism
Condition: Pulmonary Embolism
Interventions: Drug: Nitric Oxide;   Drug: Oxygen
3 Not yet recruiting Efficacy of Low (30ml) Versus Full Dose (100ml) Contrast CT Pulmonary Angiography in Detecting Emboli
Condition: Multiple Pulmonary Emboli
Interventions: Procedure: Low-Dose IV Contrast;   Device: Siemens Sensation 64-MDCT scanner.;   Drug: Visipaque 320 non-ionic isoosmolar contrast agent
4 Unknown  Modeling Genotype and Other Factors to Enhance the Safety of Coumadin Prescribing
Conditions: Atrial Fibrillation;   Deep Venous Thrombosis;   Heart Valve Replacement;   Pulmonary Embolism
Intervention: Drug: Coumadin
5 Not yet recruiting Pharmacogenetics of Warfarin in Caribbean Hispanics
Conditions: Atrial Fibrillation;   Deep Vein Thrombosis;   Cardiac Valvular Insufficiency;   Coagulopathies;   Pulmonary Embolism
Interventions: Genetic: Genotype-guided;   Other: Standard-of-Care
6 Recruiting The Spot Sign for Predicting and Treating ICH Growth Study
Condition: Intracerebral Hemorrhage
Interventions: Drug: recombinant activated factor VII;   Drug: placebo
7 Recruiting Rituximab and Belimumab for Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Biological: Rituximab;   Drug: Cyclophosphamide;   Drug: Prednisone;   Drug: Methylprednisolone;   Drug: Diphenhydramine;   Drug: Acetaminophen;   Biological: Belimumab
8 Recruiting A Randomized Trial of Induction Versus Expectant Management
Condition: Labor and Delivery
Intervention: Procedure: Elective Induction of Labor
9 Not yet recruiting Prehospital Tranexamic Acid Use for Traumatic Brain Injury
Condition: Traumatic Brain Injury
Interventions: Drug: 1 gram Tranexamic Acid (TXA);   Drug: 2 grams TXA;   Drug: 0.9% Sodium Chloride injectable
10 Not yet recruiting Topical TXA in Spine Trauma Surgery
Conditions: Spinal Injuries;   Spinal Deformity
Interventions: Drug: Tranexamic Acid;   Drug: Placebo
11 Recruiting Blood Markers of Inflammation, Blood Clotting and Blood Vessel Function in HIV-infected Adults
Condition: HIV
Intervention:
12 Recruiting Development of Computer-aided Detection and Diagnosis From Imaging Techniques
Condition: Cancer
Intervention:
13 Not yet recruiting Cancer Associated Thrombosis and Isoquercetin (CAT IQ)
Conditions: Thromboembolism of Vein VTE in Colorectal Cancer;   Thromboembolism of Vein in Pancreatic Cancer;   Thromboembolism of Vein in Non-small Cell Lung Cancer
Intervention: Drug: Isoquercetin
14 Unknown  Predictors of Anticoagulation Control on Warfarin Therapy
Conditions: Atrial Fibrillation;   Deep Vein Thrombosis;   Heart Valve Replacement
Intervention:
15 Recruiting Genetics Informatics Trial (GIFT) of Warfarin to Prevent DVT
Condition: Thromboembolism
Interventions: Genetic: Pharmacogenetic Warfarin Initiation;   Other: Clinical Warfarin Initiation

Indicates status has not been verified in more than two years